[SLN] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 170.67%
YoY- 205.12%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 0 0 8 8 385 -
PBT -4,894 -4,894 1,441 1,441 -3,328 -3,328 -2,410 60.56%
Tax 550 550 508 508 570 570 557 -0.84%
NP -4,344 -4,344 1,949 1,949 -2,758 -2,758 -1,854 76.68%
Tax Rate - - -35.30% -35.30% - - - -
Total Cost 4,344 4,344 -1,949 -1,949 2,766 2,766 2,239 55.74%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 -34,475.00 -34,475.00 -481.43 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.19 -0.19 0.08 0.08 -0.12 -0.12 -0.08 78.29%
EPS Diluted -0.19 -0.19 0.08 0.08 -0.12 -0.12 -0.08 78.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.